Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Arbutus Biopharma Corp (NASDAQ:ABUS)

2.60
Delayed Data
As of 9:30am ET
 -0.05 / -1.89%
Today’s Change
2.35
Today|||52-Week Range
5.48
+6.12%
Year-to-Date
No recent news for Arbutus Biopharma Corp.

Today’s Trading

Previous close2.65
Today’s open2.60
Day’s range2.60 - 2.60
Volume1,940
Average volume (3 months)265,990
Market cap$145.3M
Dividend yield--
Data as of 9:30am ET, 02/24/2017

Growth & Valuation

Earnings growth (last year)+25.56%
Earnings growth (this year)-181.34%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+66.34%
P/E ratio--
Price/Sales8.13
Price/Book0.26

Competitors

 Today’s
change
Today’s
% change
GLYCGlycoMimetics Inc-0.11-1.75%
FBIOFortress Biotech Inc-0.00-0.17%
VTLVital Therapies Inc-0.05-1.09%
OCXOncoCyte Corp+0.07+1.38%
Data as of 10:09am ET, 02/24/2017

Financials

Next reporting dateMarch 15, 2017
EPS forecast (this quarter)-$0.39
Annual revenue (last year)$24.9M
Annual profit (last year)-$61.1M
Net profit margin-245.73%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mark J. Murray
Chief Financial Officer &
Executive Vice President
Bruce G. Cousins
Corporate headquarters
Burnaby, British Columbia

Forecasts


Search for Jobs